Literature DB >> 3629752

Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma.

L Daehlin, A Bergh, J E Damber.   

Abstract

Male Copenhagen x Fischer F1 rats were implanted with Dunning R3327H prostatic carcinoma, castrated when the tumours became palpable and were then treated with testosterone, testosterone in combination with oestradiol or oestradiol alone for four weeks. Treatment with oestradiol produced the smallest tumours. The testosterone-stimulated growth of tumours was inhibited by oestradiol. The adenocarcinoma was moderately to well-differentiated. Morphometric analysis of the composition of the tumours showed that oestradiol stimulated tumour stroma and inhibited glandular epithelium. These effects were produced concomitantly with decreased overall tumour growth. Testosterone stimulated all cell types of the tumour.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3629752     DOI: 10.1007/BF00254431

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  14 in total

1.  Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.

Authors:  L P Susan; R B Roth; W C Adkins
Journal:  Urology       Date:  1976-06       Impact factor: 2.649

2.  In vivo metabolism of testosterone-3H in R-3327, an androgen-sensitive rat prostatic adenocarcinoma.

Authors:  W Voigt; W F Dunning
Journal:  Cancer Res       Date:  1974-06       Impact factor: 12.701

3.  Local regulation of Leydig cells by the seminiferous tubules. Effect of short-term cryptorchidism.

Authors:  A Bergh; J E Damber
Journal:  Int J Androl       Date:  1984-10

4.  Characterization of steroid hormone receptors in the Dunning R-3327 rat prostatic adenocarcinoma.

Authors:  F S Markland; R T Chopp; M D Cosgrove; E B Howard
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

5.  A comparison of a powerful luteinizing hormone releasing hormone analogue agonist and estrogen in the treatment of advanced prostatic cancer.

Authors:  H Winfield; J Trachtenberg
Journal:  J Urol       Date:  1984-06       Impact factor: 7.450

6.  Adenocarcinoma of prostate: role of 17beta-estradiol and 5alpha-dihydrotestosterone binding proteins.

Authors:  S M Sidh; J D Young; S A Karmi; J R Powder; N Bashirelahi
Journal:  Urology       Date:  1979-06       Impact factor: 2.649

7.  Comparison of the R-3327H rat prostatic adenocarcinoma to human benign prostatic hyperplasia and metastatic carcinoma of the prostate with regard to steroid hormone receptors.

Authors:  E Dahlberg; M Snochowski; J A Gustafsson
Journal:  Prostate       Date:  1980       Impact factor: 4.104

8.  Testosterone-induced decrement of prostatic vascular resistance in rats is reversed by estrogens.

Authors:  L Daehlin; J E Damber; G Selstam; B Bergman
Journal:  Prostate       Date:  1985       Impact factor: 4.104

9.  Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis.

Authors:  L Daehlin; R Södergård; J E Damber
Journal:  Scand J Clin Lab Invest       Date:  1986-04       Impact factor: 1.713

10.  Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.

Authors:  L Daehlin; J E Damber
Journal:  Urol Res       Date:  1986
View more
  4 in total

Review 1.  The future of antihormone therapy: innovations based on an established principle.

Authors:  K Parczyk; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.

Authors:  M Landström; J E Damber; A Bergh; R Tomic
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 3.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

4.  The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat.

Authors:  M R Schneider; A Humm; A H Graf
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.